PGR · Western blot design guide

PGR Western Blot Planning Guide

Plan a PGR Western blot around the catalog-observed 99 kDa band, image-backed PA1413 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for PGR (PGR): expected band 99 kDa, antibody PA1413, and PMC-cited SDS-PAGE protocol steps
PGR Western blot protocol sheet — expected band 99 kDa, antibody PA1413, controls and PMC citations. Open the full PGR WB guide →

PGR Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 99 kDa
Observed band Not reported — verify product WB image
Gel 8-10%
Positive control ⓘ Cervix
Negative control ⓘ Appendix
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 99 kDa
ⓘ Localization Nucleus / Cytoplasm
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Human
Section 1

Real Curated PGR Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateCervix
Gel %8-10%
Load20-30 µg total protein per lane
TransferSemi-dry, standard transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPA1413 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected PGR Western Blot Band Size?

Use the product-observed 99 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
99 kDaMatches the authoritative product WB observation.
99 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected PGR appearancePlan around 99 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band99 kDa; use this as the primary experimental expectation.
Calculated mass99 kDa from UniProt P06401; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PA1413.
Why is my band missing or off?
SituationLikely causeNext action
99 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for PGR Western blot

🧪Use Cervix as the first positive-control candidate and Appendix as the HPA Not detected negative candidate.
Positive control: Cervix (High)
Negative control: Appendix (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for PGR

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Cervix Reported tissue cells High Protein (HPA) HPA →
Fallopian tube Reported tissue cells High Protein (HPA) HPA →
Endometrium Reported tissue cells High Protein (HPA) HPA →
Smooth muscle Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced PGR Western Blot Tips

Deeper troubleshooting and optimisation questions for PGR, answered from its protein features.

Which band should guide the blot?
Use 99 kDa, the observation attached to the authoritative PA1413 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 99 kDa expectation.
Which positive control should I start with?
Start with Cervix, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Appendix as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for PGR Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PA1413 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
Compare only the supplied target-verified records: PMC13403224, PMC2847056, PMC12451540.
Boster reagents

PGR Western Blot Reagents

Human-reactive PGR Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for PGR using PA1413; observed band 99 kDa
Anti-Progesterone Receptor/PGR Antibody Picoband®
Cat # PA1413
Real WB data Western blot validation image for PGR using PB9009; observed band 99 kDa
Anti-Progesterone Receptor/PGR Antibody Picoband®
Cat # PB9009

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.